Literature DB >> 20532480

Serum insulin-like growth factor-I is a marker for assessing the severity of vertebral fractures in postmenopausal women with type 2 diabetes mellitus.

I Kanazawa1, T Yamaguchi, T Sugimoto.   

Abstract

UNLABELLED: Although previous studies indicated that serum insulin-like growth factor-I (IGF-I) was inversely associated with the presence of vertebral fractures (VFs), little is known whether serum IGF-I is associated with multiple VFs. We report that serum IGF-I could be clinically useful for assessing the severity of VFs in type 2 diabetic postmenopausal women.
INTRODUCTION: The number of VFs is associated with the mobility and mortality of the elderly people. Although serum IGF-I is inversely associated with the presence of VFs, little is known about the relationship between serum IGF-I and multiple VFs.
METHODS: In this cross-sectional study, we recruited 479 men and 334 postmenopausal women with type 2 diabetes mellitus and measured serum IGF-I, bone mineral density, and bone turnover markers. Lateral X-ray films of the thoracic and lumbar spine were taken to diagnose the VF.
RESULTS: In postmenopausal women, serum IGF-I level was decreased when the number of VFs was increased [no VFs; 138 ± 51 ng/ml (mean ± SD) vs. one VF; 119 ± 42 (p = 0.006), two VFs; 103 ± 39 (p = 0.002), and three and more VFs; 91 ± 40 (p < 0.001)]. Multiple logistic regression analysis adjusted for age, duration of diabetes, body mass index, serum creatinine, and HbA(1c) showed that serum IGF-I level was inversely associated with the presence of one VF [odds ratio (OR) = 0.67, p = 0.029], two VFs (OR = 0.40, p = 0.017), as well as three and more VFs (OR = 0.27, p = 0.005). These associations were still significant after the additional adjustment for BMD at the lumbar spine. In contrast, no significant association of serum IGF-I level with VFs was found in men.
CONCLUSIONS: Serum IGF-I level was inversely associated with the number of prevalent VFs in postmenopausal women with type 2 diabetes, suggesting that serum IGF-I could be clinically useful for assessing the severity of VFs in the population.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20532480     DOI: 10.1007/s00198-010-1310-6

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  37 in total

1.  Insulin-like growth factor I stimulates bone turnover in osteoporosis.

Authors:  A G Johansson; E Lindh; S Ljunghall
Journal:  Lancet       Date:  1992-06-27       Impact factor: 79.321

2.  Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.

Authors:  T Sugimoto; K Nishiyama; F Kuribayashi; K Chihara
Journal:  J Bone Miner Res       Date:  1997-08       Impact factor: 6.741

3.  Mortality after all major types of osteoporotic fracture in men and women: an observational study.

Authors:  J R Center; T V Nguyen; D Schneider; P N Sambrook; J A Eisman
Journal:  Lancet       Date:  1999-03-13       Impact factor: 79.321

Review 4.  Insulin-like growth factor-I in diabetes mellitus: its physiology, metabolic effects, and potential clinical utility.

Authors:  K M Thrailkill
Journal:  Diabetes Technol Ther       Date:  2000       Impact factor: 6.118

5.  The effects of insulin and growth hormone on the release of somatomedin by the isolated rat liver.

Authors:  W H Daughaday; L S Phillips; M C Mueller
Journal:  Endocrinology       Date:  1976-05       Impact factor: 4.736

6.  Circulating levels of IGF-1 directly regulate bone growth and density.

Authors:  Shoshana Yakar; Clifford J Rosen; Wesley G Beamer; Cheryl L Ackert-Bicknell; Yiping Wu; Jun-Li Liu; Guck T Ooi; Jennifer Setser; Jan Frystyk; Yves R Boisclair; Derek LeRoith
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

7.  Diabetic osteopathy and the IGF system in the Goto-Kakizaki rat.

Authors:  Tashfeen Ahmad; Anna Ugarph-Morawski; Moira S Lewitt; Jian Li; Maria Sääf; Kerstin Brismar
Journal:  Growth Horm IGF Res       Date:  2008-04-01       Impact factor: 2.372

8.  Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications.

Authors:  Masahiro Yamamoto; Toru Yamaguchi; Mika Yamauchi; Hiroshi Kaji; Toshitsugu Sugimoto
Journal:  J Bone Miner Res       Date:  2009-04       Impact factor: 6.741

9.  Serum osteocalcin/bone-specific alkaline phosphatase ratio is a predictor for the presence of vertebral fractures in men with type 2 diabetes.

Authors:  Ippei Kanazawa; Toru Yamaguchi; Masahiro Yamamoto; Mika Yamauchi; Shozo Yano; Toshitsugu Sugimoto
Journal:  Calcif Tissue Int       Date:  2009-07-30       Impact factor: 4.333

10.  Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosis The Study of Osteoporotic Fractures Research Group.

Authors:  H K Genant; M Jergas; L Palermo; M Nevitt; R S Valentin; D Black; S R Cummings
Journal:  J Bone Miner Res       Date:  1996-07       Impact factor: 6.741

View more
  17 in total

Review 1.  Type 2 diabetes and bone fractures.

Authors:  Kendall F Moseley
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2012-04       Impact factor: 3.243

Review 2.  Current, new and future treatments of osteoporosis.

Authors:  Pooneh Salari Sharif; Mohammad Abdollahi; Bagher Larijani
Journal:  Rheumatol Int       Date:  2010-07-30       Impact factor: 2.631

3.  Bone cells and bone turnover in diabetes mellitus.

Authors:  Mishaela R Rubin
Journal:  Curr Osteoporos Rep       Date:  2015-06       Impact factor: 5.096

Review 4.  Assessment of bone quality in patients with diabetes mellitus.

Authors:  N Jiang; W Xia
Journal:  Osteoporos Int       Date:  2018-05-07       Impact factor: 4.507

5.  1α,25-Dihydroxyvitamin D3 promotes bone formation by promoting nuclear exclusion of the FoxO1 transcription factor in diabetic mice.

Authors:  Yi Xiong; Yixin Zhang; Na Xin; Ying Yuan; Qin Zhang; Ping Gong; Yingying Wu
Journal:  J Biol Chem       Date:  2017-10-17       Impact factor: 5.157

6.  Effects of intensive glycemic control on serum levels of insulin-like growth factor-I and dehydroepiandrosterone sulfate in Type 2 diabetes mellitus.

Authors:  I Kanazawa; T Yamaguchi; T Sugimoto
Journal:  J Endocrinol Invest       Date:  2011-10-10       Impact factor: 4.256

7.  Overweight and underweight are risk factors for vertebral fractures in patients with type 2 diabetes mellitus.

Authors:  Ippei Kanazawa; Masakazu Notsu; Ayumu Takeno; Ken-Ichiro Tanaka; Toshitsugu Sugimoto
Journal:  J Bone Miner Metab       Date:  2018-09-20       Impact factor: 2.626

8.  Sex-specific associations of serum insulin-like growth factor-1 with bone density and risk of fractures in Chinese patients with type 2 diabetes.

Authors:  F Lv; X Cai; R Zhang; L Zhou; X Zhou; X Han; L Ji
Journal:  Osteoporos Int       Date:  2021-01-07       Impact factor: 4.507

Review 9.  Diabetes, diabetic complications, and fracture risk.

Authors:  Ling Oei; Fernando Rivadeneira; M Carola Zillikens; Edwin H G Oei
Journal:  Curr Osteoporos Rep       Date:  2015-04       Impact factor: 5.096

Review 10.  Assessment of bone turnover and bone quality in type 2 diabetic bone disease: current concepts and future directions.

Authors:  Mishaela R Rubin; Janina M Patsch
Journal:  Bone Res       Date:  2016-03-22       Impact factor: 13.567

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.